# Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer

> **NCT01807156** · PHASE2 · TERMINATED · sponsor: **Emory University** · enrollment: 7 (actual)

## Conditions studied

- Hepatocellular Cancer

## Interventions

- **DRUG:** Tivozanib

## Key facts

- **NCT ID:** NCT01807156
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-03
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Primary endpoint not met
- **Last updated:** 2016-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01807156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01807156, "Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01807156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*